MEDTECH & PHARMA PLATFORM

Innovative approaches for patients’ health through joint pharma, medtech and digital technologies

About the MPP Association

Fostering synergies between the medtech, pharmaceutical and digital sectors

The Medtech & Pharma Platform (MPP) Association focuses on the combined use of health technologies, including:

  • Medicinal products
  • Medical devices
  • Digital technologies e.g. software,
    mobile platform for a medical purpose.

MPP Association

The MPP is a European industry association representing medtech, pharmaceutical and tech companies active in the field of combined products.

MPP Association

The MPP is a European industry association representing medtech, pharmaceutical and tech companies active in the field of combined products.

Advocacy

The MPP conducts advocacy work to facilitate market access for combined products.

Advocacy

The MPP conducts advocacy work to facilitate market access for combined products.

Members

The MPP members are leading companies in the fields of pharmaceutical, medtech and tech that are active in Europe and share the common objective of improving human health and conditions of life.

Members

The MPP members are leading companies in the fields of pharmaceutical, medtech and tech that are active in Europe and share the common objective of improving human health and conditions of life.

Annual Conference & events

The MPP Annual Conference is dedicated to presenting the latest products, solutions and regulatory developments for combined products. The MPP also hosts events to foster knowledge exchange.

Annual Conference & events

The MPP Annual Conference is dedicated to presenting the latest products, solutions and regulatory developments for combined products. The MPP also hosts events to foster knowledge exchange.

MPP latest news and upcoming events

Dec 18 2025

MPP Association Welcomes European Commission’s Proposal to Amend MDR and IVDR To Foster Innovation

Medtech & Pharma Platform Association (MPP) welcomes the European Commission’s publication of the long-awaited...
Oct 25 2024

MPP Association letter to European Commission on MDR/IVDR targeted assessment

In the context of the anticipated targeted assessment of the Medical Devices and In Vitro Diagnostics Regulations (MDR...
Oct 25 2024

MPP publishes position paper on impact of IVDR on use of in-house devices in clinical trials

The Medtech & Pharma Platform Association (MPP) is pleased to announce the publication of a paper entitled ‘Impact...
Oct 21 2024

11th edition of the Medtech & Pharma Platform Association annual conference

21 October 2024 – Press release The 11th Medtech & Pharma Platform Association (MPP) Annual Conference (MPP 2024)...
Sep 03 2024

The 11th edition of the Medtech & Pharma Platform Association annual conference kicks-off in Basel

3 September 2024 – Press release Today, the MPP Annual Conference, themed “Combined products of tomorrow – developing...
Jul 03 2024

MDx CRO joins the MPP

We proudly welcome MDx CRO as the newest member of the Medtech & Pharma Platform (MPP) Association. We look...
Jul 03 2024

Nomination of Designated Vice-President

At its last meeting in June 2024, the MPP Board of Directors put forward the proposal to nominate a Vice-President of...
May 16 2024

MPP Association welcomes Gerresheimer as member

We are delighted to announce that Gerresheimer has become a member of the MPP Association, the leading European...
Apr 29 2024

Outcome of the 2024 MPP General Assembly

The Medtech & Pharma Platform (MPP) Association held its annual General Assembly meeting on 29 April 2024. MPP...
Mar 14 2024

MPP Association statement on the AI ACT

The MPP Association welcomes the adoption of the EU artificial intelligence (AI) Act by the European Parliament on 13...